Zelleka Getahun v. Office Of The Chief Administrative Hearing Officer Of The Executive Office For Immigration Review Of The United States Department Of Justice

124 F.3d 591, 1997 U.S. App. LEXIS 24204
CourtCourt of Appeals for the Third Circuit
DecidedSeptember 15, 1997
Docket96-3531
StatusPublished

This text of 124 F.3d 591 (Zelleka Getahun v. Office Of The Chief Administrative Hearing Officer Of The Executive Office For Immigration Review Of The United States Department Of Justice) is published on Counsel Stack Legal Research, covering Court of Appeals for the Third Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Zelleka Getahun v. Office Of The Chief Administrative Hearing Officer Of The Executive Office For Immigration Review Of The United States Department Of Justice, 124 F.3d 591, 1997 U.S. App. LEXIS 24204 (3d Cir. 1997).

Opinion

124 F.3d 591

Zelleka GETAHUN, Petitioner,
v.
OFFICE OF THE CHIEF ADMINISTRATIVE HEARING OFFICER OF THE
EXECUTIVE OFFICE FOR IMMIGRATION REVIEW OF THE
UNITED STATES DEPARTMENT OF JUSTICE,
DuPont Merck Pharmaceutical Company, Intervenor-Respondent.

No. 96-3531.

United States Court of Appeals,
Third Circuit.

Submitted Pursuant to Third Circuit LAR 34.1(a)
July 24, 1997.
Decided Sept. 15, 1997.

Ann M. Badmus, Newark, DE, for Petitioner.

Robert J. Smith, Morgan, Lewis & Bockius, Washington, DC, for Intervenor-Respondent.

Before: SCIRICA and NYGAARD, Circuit Judges and DEBEVOISE, Senior District Judge.*OPINION OF THE COURT

DEBEVOISE, Senior District Judge.

Petitioner, Dr. Zelleka Getahun, filed a complaint with the United States Department of Justice's Executive Office for Immigration Review, Office of the Chief Administrative Hearing Officer ("OCAHO") pursuant to 8 U.S.C. § 1324b(d)(2), charging that her former employer, Intervenor-Respondent DuPont Merck Pharmaceutical Company ("DuPont Merck"), committed "document abuse" in violation of 8 U.S.C. § 1324b(a)(6) when it terminated her employment on October 27, 1993. The Administrative Law Judge to whom the case was assigned granted DuPont Merck's motion for summary decision, holding that Dr. Getahun was not authorized to accept employment in the United States and thus lacked standing to assert a claim under § 1324b. Dr. Getahun filed a petition for review in this Court.

We will reverse the order of the ALJ dismissing Dr. Getahun's complaint and remand the case for further proceedings in accordance with this opinion.

A. The Facts

On January 10, 1991 Dr. Getahun began employment with DuPont Merck. She had previously applied for political asylum and had received an employment authorization document which had a November 1991 expiration date. At the time of her employment with DuPont Merck she completed the mandatory INS Form I-9 and submitted her Maryland driver's license and her Social Security number card as evidence of her employability. She attested on the Form I-9 that she was an alien authorized by the INS to work in the United States but did not complete the blank space calling for the expiration date of her employment authorization.

On October 25, 1991 Dr. Getahun's application for political asylum was granted. Pursuant to 8 C.F.R. § 208.20, as in effect in 1991, employment authorization was automatically granted or continued for persons granted asylum:

When an alien's application for asylum is granted, he is granted asylum status for an indefinite period. Employment authorization is automatically granted or continued for persons granted asylum or withholding of deportation unless the alien is detained pending removal to a third country. Appropriate documentation showing employment authorization shall be provided by the INS.

However, 8 C.F.R. § 274a.12 provides that an alien granted asylum "who seeks to be employed in the United States, must apply to the Service for a document evidencing such employment authorization."

In November 1991 Dr. Getahun informed DuPont Merck's Human Resources Department that her application for political asylum had been granted. A department representative informed her that DuPont Merck would assist her in adjusting her status to permanent resident. Dr. Getahun applied neither for permanent residency nor for a new EAD based upon the grant of political asylum.

In October 1993 DuPont Merck's Human Resources Department, in conjunction with its Legal Department, instituted an internal audit of the Form I-9 of each employee to ensure that it was in compliance with the Immigration Reform and Control Act of 1986 ("IRCA"), 8 U.S.C. § 1324. Dr. Getahun's Form I-9 was among those found to be defective. It failed to set forth the date on which her EAD expired.

On October 21 Mary Beth Desmond of DuPont Merck's Human Resources Department brought this to Dr. Getahun's attention. The next day Dr. Getahun met with other members of the department. The parties' accounts of what was said differ. Dr. Getahun asserts that she was informed that she had to obtain a receipt evidencing her application for permanent residence and that if she did not provide such a receipt by October 27, 1993 she would be terminated.

Whatever the substance of the conversation, on October 25, 1993 Dr. Getahun gave a certified copy of the Memorandum of Decision and Order granting her political asylum to the Human Resources Department. She also went to the INS office in Philadelphia to apply for permanent residence. The INS clerk would not accept her application because she did not have her birth certificate from Ethiopia. However, on the advice of the clerk she applied for an EAD based upon her political asylum status and obtained a document fee receipt. On the morning of October 27 Dr. Getahun returned to the INS with her birth certificate and filed for permanent residence, obtaining the appropriate document fee receipt.

Also on October 27 DuPont Merck's Human Resources Department called Dr. Getahun to schedule an appointment. When Dr. Getahun appeared she provided the fee receipts for the applications for permanent residence and for the EAD. Nevertheless the Department proceeded with the termination.1 It provided Dr. Getahun with a letter of termination which stated that even though she had presented a valid U.S. driver's license and Social Security card containing no limitation on engaging in authorized employment, because her interim EAD had expired, "DuPont Merck is required by law to ask you for additional documents to establish your eligibility to engage in lawful employment with DuPont Merck."

DuPont Merck rejected Dr. Getahun's two document receipts evidencing her application for permanent residency and for an asylum-based EAD purportedly on the advice of an official at the INS office of the General Counsel in Washington, D.C., with whom DuPont Merck's legal counsel had communicated. The letter of termination stated that DuPont Merck had been "advised that an employer may accept a receipt for a replacement document if the employee completes section 1 on Form I-9 by indicating either that he or she is a U.S. permanent resident or a foreign national authorized to work until a specified date." The letter further stated, in effect, that since Dr. Getahun could not provide an expiration date of her work authorization, she could not rely on the receipts. As will be described below, DuPont Merck's rationale with respect to the document receipts constituted a misapplication of the INS legal memorandum upon which it apparently relied and an erroneous interpretation of the applicable law and regulations.

B. The ALJ's Decision

Dr. Getahun filed a charge of document abuse against DuPont Merck with the United States Department of Justice's Office of Special Counsel ("OSC") as permitted by 8 U.S.C. § 1324b(b)(1).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
124 F.3d 591, 1997 U.S. App. LEXIS 24204, Counsel Stack Legal Research, https://law.counselstack.com/opinion/zelleka-getahun-v-office-of-the-chief-administrative-hearing-officer-of-ca3-1997.